Your browser doesn't support javascript.
loading
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B.
Adler-Moore, Jill; Lewis, Russell E; Brüggemann, Roger J M; Rijnders, Bart J A; Groll, Andreas H; Walsh, Thomas J.
Affiliation
  • Adler-Moore J; Department of Biological Sciences, California State Polytechnic University, Pomona.
  • Lewis RE; Unit of Infectious Diseases, Policlinico Sant'Orsola-Malpighi, Department of Medical Sciences and Surgery, University of Bologna, Italy.
  • Brüggemann RJM; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Rijnders BJA; Department of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Groll AH; Infectious Disease Research Program, Department of Pediatric Hematology and Oncology and Center for Bone Marrow Transplantation, University Children's Hospital Muenster, Germany.
  • Walsh TJ; Departments of Medicine, Pediatrics, and Microbiology & Immunology, Weill Cornell Medicine of Cornell University, New York, New York.
Clin Infect Dis ; 68(Suppl 4): S244-S259, 2019 05 02.
Article in En | MEDLINE | ID: mdl-31222254

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amphotericin B / Invasive Fungal Infections / Fungi / Antifungal Agents Type of study: Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amphotericin B / Invasive Fungal Infections / Fungi / Antifungal Agents Type of study: Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2019 Type: Article